Shares of UnitedHealth Group Incorporated (NYSE:UNH) have been assigned an average recommendation of “Buy” from the twenty-six analysts that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and twenty-five have given a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $202.38.
A number of equities research analysts recently weighed in on UNH shares. Vetr raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price target for the company in a report on Monday, May 15th. UBS AG reaffirmed an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, August 24th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $199.00 price target for the company in a report on Tuesday, May 30th. BidaskClub raised UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 8th. Finally, Morgan Stanley raised their price target on UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, June 28th.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the transaction, the director now directly owns 60,834 shares in the company, valued at $12,135,774.66. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total value of $2,875,650.00. Following the transaction, the director now owns 1,818,898 shares in the company, valued at $348,700,935.58. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 25,600 shares of company stock worth $4,962,694. Corporate insiders own 0.89% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Retirement Systems of Alabama lifted its holdings in UnitedHealth Group by 2.5% during the first quarter. Retirement Systems of Alabama now owns 640,240 shares of the healthcare conglomerate’s stock worth $105,006,000 after acquiring an additional 15,403 shares in the last quarter. Honeywell International Inc. bought a new position in UnitedHealth Group during the first quarter worth about $35,262,000. Harwood Advisory Group LLC lifted its holdings in UnitedHealth Group by 0.8% during the first quarter. Harwood Advisory Group LLC now owns 1,885 shares of the healthcare conglomerate’s stock worth $309,000 after acquiring an additional 15 shares in the last quarter. Mn Services Vermogensbeheer B.V. lifted its holdings in UnitedHealth Group by 3.9% during the first quarter. Mn Services Vermogensbeheer B.V. now owns 25,730 shares of the healthcare conglomerate’s stock worth $3,946,000 after acquiring an additional 970 shares in the last quarter. Finally, Suntrust Banks Inc. lifted its holdings in UnitedHealth Group by 8.5% during the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock worth $42,774,000 after acquiring an additional 20,541 shares in the last quarter. Hedge funds and other institutional investors own 86.21% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was reported by Markets Daily and is the property of of Markets Daily. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. & international copyright law. The correct version of this report can be read at https://www.themarketsdaily.com/2017/09/10/unitedhealth-group-incorporated-unh-given-consensus-recommendation-of-buy-by-brokerages.html.
UnitedHealth Group (NYSE UNH) traded down 0.21% on Tuesday, hitting $197.75. The stock had a trading volume of 2,205,962 shares. The firm has a market cap of $191.20 billion, a P/E ratio of 23.76 and a beta of 0.63. UnitedHealth Group has a 1-year low of $132.39 and a 1-year high of $200.44. The firm’s 50-day moving average price is $194.18 and its 200-day moving average price is $179.36.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. During the same period last year, the firm posted $1.96 EPS. The business’s revenue was up 7.7% on a year-over-year basis. On average, equities research analysts predict that UnitedHealth Group will post $9.87 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be issued a dividend of $0.75 per share. The ex-dividend date is Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 35.13%.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.